MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10620-025-09072-1

Медицинская библиотека · Digestive diseases and sciences · 2025

Liver Transplantation and Metabolic Dysfunction Associated Steatotic Liver Disease Is Associated with Markers of Metabolic Risk and Inflammation.

Razzaq Rehan, Nguyen Madison, Connelly Margery A, Baral Alok, Khan Hiba, Garg Shreya, Ang Audrey, Kim Alexis, Roache Geneva, Patidar Kavish R, Yakubu Idris, Shalaurova Irina, Bakker Stephan J L, Dullaart Robin P F, Kumaran Vinay, Bui Anh T, Patel Vaishali, Siddiqui Mohammad Shadab

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Liver transplant (LT) recipients are at high risk of cardiometabolic disease and mortality. However, routinely employed clinical risk tools have sub-optimal diagnostic performance due to transplant related biological changes. Metabolic vulnerability index (MVX) is a serum-based composite biomarker comprised of nutritional risk [metabolic malnutrition index or MMX] and chronic inflammation [inflammatory vulnerability index or IVX]. MVX is a predictor of cardiovascular risk and all-cause mortality in the general population, however, the effect of LT on MVX is unknown.

METHODS

To better quantify MVX after transplantation, LT recipients (n = 181) prospectively enrolled in a natural history study were matched with non transplant controls from the MESA study of healthy individuals. All controls were matched 1:1 regarding age and gender. Additionally, lean controls were identified as those with BMI < 25 kg/m2 and BMI-matched controls who were propensity matched for BMI.

RESULTS

Compared to matched controls, LT recipients had significantly higher MVX (56.9 ± 10.1 vs. 45.8 ± 9.4 vs. 44.8 ± 9.3, p < 0.001), IVX [53.1 ± 12 vs. 39.3 ± 11.2 vs. 40.2 ± 10.9, p < 0.001), and MMX (58.7 ± 8.2 vs. 55.4 ± 6.5 vs. 53.1 ± 6.0, p < 0.001). No significant differences were noted in MVX in LT recipients who developed metabolic dysfunction associated steatotic liver disease (MASLD) after LT. In a multivariate analysis, MVX scores were positively associated with female gender, diabetes, serum AST and BMI, and negatively with dyslipidemia.

CONCLUSION

LT is associated with a significant increase in MVX and its components, suggesting a heightened risk in LT recipients that is above that of the non-LT population. Future well designed prospective studies are required to calibrate MVX to clinical outcomes in LT patients.

Для цитирования: Razzaq Rehan, Nguyen Madison, Connelly Margery A, Baral Alok, Khan Hiba, Garg Shreya, Ang Audrey, Kim Alexis, Roache Geneva, Patidar Kavish R, Yakubu Idris, Shalaurova Irina, Bakker Stephan J L, Dullaart Robin P F, Kumaran Vinay, Bui Anh T, Patel Vaishali, Siddiqui Mohammad Shadab. Liver Transplantation and Metabolic Dysfunction Associated Steatotic Liver Disease Is Associated with Markers of Metabolic Risk and Inflammation.. Digestive diseases and sciences. 2025. DOI: 10.1007/s10620-025-09072-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.